Showing results (1041-1050 of 1,604) with videos related to

Sort By:
Pageof 161
JAMA Dermatology|December 29, 2021
Assessment of the Diagnostic Accuracy of Baseline Clinical Examination and Ultrasonographic Imaging for the Detection of Lymph Node Metastasis in Patients With High-risk Cutaneous Squamous Cell Carcinoma of the Head and NeckSelin Tokez, Fabiënne H J Koekelkoren, Robert J Baatenburg de Jong, et al.
JAMA Dermatology|January 5, 2022
Patient Impressions and Outcomes After Clinic-Based Hidradenitis Suppurativa SurgerySaranya Ravi, Jonathan A Miles, Chelsea Steele, et al.
JAMA Dermatology|October 26, 2022
Evaluation of Hidradenitis Suppurativa Diagnostic Criteria in Pediatric PatientsNicole W Kittler, Jazzmin C Williams, Margaret V Kudlinski, et al.
JAMA Dermatology|November 2, 2022
Follow-up of Patients With Keratinocyte Carcinoma: A Systematic Review of Clinical Practice GuidelinesSara Mirali, Evan Tang, Aaron M Drucker, et al.
JAMA Dermatology|October 12, 2022
Measuring Atopic Eczema Control and Itch Intensity in Clinical Practice: A Consensus Statement From the Harmonising Outcome Measures for Eczema in Clinical Practice (HOME-CP) InitiativeYael A Leshem, Joanne R Chalmers, Christian Apfelbacher, et al.
JAMA Dermatology|September 14, 2022
Effect of Different Itraconazole Dosing Regimens on Cure Rates, Treatment Duration, Safety, and Relapse Rates in Adult Patients With Tinea Corporis/Cruris: A Randomized Clinical TrialAnanta Khurana, Aastha Agarwal, Diksha Agrawal, et al.
JAMA Dermatology|September 21, 2022
Association of Apremilast With Vascular Inflammation and Cardiometabolic Function in Patients With Psoriasis: The VIP-A Phase 4, Open-label, Nonrandomized Clinical TrialJoel M Gelfand, Daniel B Shin, April W Armstrong, et al.
JAMA Dermatology|October 5, 2022
Apremilast in Recalcitrant Cutaneous Dermatomyositis: A Nonrandomized Controlled TrialCarole Bitar, Thien Ninh, Katherine Brag, et al.
JAMA Dermatology|October 6, 2021
Assessment of Clinical and Laboratory Use of the Cutaneous Direct Immunofluorescence AssayJulie D R Reimann, Sean P Moynihan, Thomas D Horn
JAMA Dermatology|May 16, 2019
Characteristics of State and Federal Malpractice Litigation of Medical Liability Claims for Keratinocyte Carcinoma, 1968 to 2018Raghav Tripathi, Harib H Ezaldein, Krithika Rajkumar, et al.
Pageof 161